Status | Study |
Completed |
Study Name: Pilot Study of Fostamatinib Disodium/R935788 for the Treatment of Adult Refractory Immune Thrombocytopenic Purpura (ITP) Condition: Purpura, Thrombocytopenic, Idiopathic Date: 2008-06-25 Interventions: Drug: Fostamatinib Disodium / R935788 R935788 tablets |
Completed |
Study Name: Oral LGD-4665 Versus Placebo in Adults With Immune Thrombocytopenic Purpura (ITP) for 6 Weeks Plus Open Treatment Continuation Condition: Immune Thrombocytopenic Purpura Date: 2008-02-12 Interventions: Drug: LGD-4665 LGD-4665 Thromb |
Completed |
Study Name: Clinical Evaluation of SB-497115-GR in Chronic Idiopathic Thrombocytopenic Purpura (ITP) Condition: Chronic Idiopathic Thrombocytopenic Purpura Date: 2007-10-05 Interventions: Drug: SB-497115-GR 12.5mg SB-4 |
Completed |
Study Name: Study of AKR-501 Tablets Taken Orally Once Daily for 28 Days in Patients With Chronic Idiopathic Thrombocytopenic Purpura (ITP) Condition: Chronic Idiopathic Thrombocytopenic Purpura Date: 2007-02-27 Interventions: Drug: Placebo Placebo Tablets |
Completed |
Study Name: Repeated Exposure to Eltrombopag in Adults With Idiopathic Thrombocytopenic Purpura (REPEAT) Condition: Purpura, Thrombocytopaenic, Idiopathic Date: 2007-01-17 Interventions: Drug: eltrombopag experimental |
Completed |
Study Name: Pilot Study of Rituximab for the Treatment of Acute Immune Thrombocytopenic Purpura (ITP) Condition: Purpura, Thrombocytopenic, Idiopathic Date: 2006-09-06 Interventions: Drug: Rituximab 375mg/m2 per w |
Terminated |
Study Name: Safety Study of GMA161 in Patients With Idiopathic Thrombocytopenic Purpura (ITP) Condition: Idiopathic Thrombocytopenic Purpura Date: 2005-10-25 Interventions: Biological: GMA161 0.1 mg/kg, |
Completed |
Study Name: Rapid Infusion Of Immune Globulin Intravenous (IGIV) In Patients With ITP Condition: Purpura, Thrombocytopenic, Idiopathic Date: 2005-09-13 Interventions: Drug: Immune Globulin IV [Human], 10% Caprylate/Chromatography Purified IGIV-C 10% at a dose of 1.0g/kg |
Completed |
Study Name: Efficacy and Safety Study of a 10% Triple Virally Reduced Intravenous Immune Globulin Solution in Adult Subjects With Chronic Idiopathic Thrombocytopenic Purpura Condition: Idiopathic Thrombocytopenic Purpura Date: 2005-09-08 Interventions: Drug: Immune Globulin Intravenous (Human), 10% Triple Virally Reduced Solution |
Completed |
Study Name: Efficacy and Safety of IVIG-L in ITP Patients Condition: Purpura, Thrombocytopenic, Idiopathic Date: 2005-09-08 Interventions: Drug: IVIG-L |